![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 205/04 | |
A61K 31/397 | |||
A61P 29/00 | |||
A61P 31/06 | |||
A61P 31/08 | |||
A61P 21/00 |
(11) | Number of the document | 2379498 |
(13) | Kind of document | T |
(96) | European patent application number | 09793423.6 |
Date of filing the European patent application | 2009-12-17 | |
(97) | Date of publication of the European application | 2011-10-26 |
(45) | Date of publication and mention of the grant of the patent | 2015-01-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2009/068346 |
Date | 2009-12-17 |
(87) | Number | WO 2010/071794 |
Date | 2010-06-24 |
(30) | Number | Date | Country code |
203052 P | 2008-12-18 | US |
(72) |
LIU, Yugang, US
PAPOUTSAKIS, Dimitris, US
RODDY, Elizabeth, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | POLYMORPHIC FORM OF 1-(4-{1-[(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL) -AZETIDINE-3-CARBOXYLIC ACID |
POLYMORPHIC FORM OF 1-(4-{1-[(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL) -AZETIDINE-3-CARBOXYLIC ACID |